India’s drug regulator’s monthly quality report highlights systemic problems in pharmaceutical manufacturing across states.
The details provided focus on India’s, offering context that helps frame the broader story. This information adds depth to the initial report.
Additional details are expected to become available as the situation continues to develop.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://drugscontrol.org/news-detail.php?newsid=45204